Mark Miglarese - Concepedia

Author

Mark Miglarese

Also Known As

M Miglarese, M R Miglarese, M. Miglarese, M. R. Miglarese, Mark Miglarese, Mark R Miglarese, Mark R. Miglarese, Mark Robert Miglarese

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Virginia Caris Life Sciences (United States)University of Bonn Center of Advanced European Studies and Research The University of Texas MD Anderson Cancer Center

About

Mark Miglarese is an author at University of Virginia specializing in medicine, cell biology, and signal transduction.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	657
2	Cell Biology	7	7	646
3	Natural Sciences	2	2	110
4	Cellular Physiology	2	2	115
5	Immunology	2	2	231

Mark Miglarese

Publications

919

Citations

H-Index

Page 1

	Year	Citations
Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer Elizabeth Buck, Prafulla C. Gokhale, Susan Koujak, Molecular Cancer Therapeutics Igf-1r InhibitionTumor BiologySignal TransductionGrowth HormoneReceptor Tyrosine Kinase	2010	216
Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors Elizabeth Buck, Alexandra Eyzaguirre, Maryland Rosenfeld-Franklin, Cancer Research Small Molecule InhibitorsTumor BiologyReceptor Tyrosine KinaseGrowth InhibitionCell Signaling	2008	209
Reduced VEGF Production, Angiogenesis, and Vascular Regrowth Contribute to the Antitumor Properties of Dual mTORC1/mTORC2 Inhibitors Beverly L. Falcón, Sharon Barr, Prafulla C. Gokhale, Cancer Research	2011	91
Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain. Natasha Aziz, Mark Miglarese, Ronald C. Hendrickson, Proceedings of the National Academy of Sciences Negative Regulatory DomainMolecular RegulationMolecular BiologyTryptic PhosphopeptidesCellular Physiology	1995	80
Epithelial–Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines Hui Zhao, Vidhi Desai, Jian Wang, Molecular Cancer Therapeutics Type 1OncologyHcc Cell LinesTumor MicroenvironmentEmt Status	2011	61
Differential Regulation of c-Myb-induced Transcription Activation by a Phosphorylation Site in the Negative Regulatory Domain Mark Miglarese, Alison F. Richardson, Natasha Aziz, Journal of Biological Chemistry	1996	57
Plasma Exosome Profiling of Cancer Patients by a Next Generation Systems Biology Approach Valeriy Domenyuk, Zhenyu Zhong, Adam Stark, Scientific Reports	2017	49
The protein tyrosine kinase substrate cortactin is differentially expressed in murine B lymphoid tumors. Mark Miglarese, J Mannion-Henderson, H. Wu, PubMed	1994	41
Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1 Ruth Halaban, Enhao Cheng, Y Zhang, Oncogene Overexpressed Mutant E2f1e132Signal TransductionCell RegulationCell DivisionMouse Melanocytes	1998	35
ADAPT identifies an ESCRT complex composition that discriminates VCaP from LNCaP prostate cancer cell exosomes Tassilo Hornung, Heather A. O’Neill, Stephen Logie, Nucleic Acids Research Escrt Complex CompositionMolecular BiologyExtracellular MicrovesiclesCancer BiologyNucleic Acid Biomarkers	2020	30

Page 1